A highly cited 2020 umbrella meta-analysis of 37 randomized controlled trials concluded that L-carnitine supplementation provides a modest but significant reducing effect on body weight, body mass index (BMI), and fat mass
Figure 10 In addition to the sulfonamides, e.g., 40 and 41 , the spiro-oxindole dihydroquinazolinone derivative 42 was identified in the screening campaign and subsequently a large series of related analogues were made, e.g., by applying rapid MW-assisted reactions and thereafter examined as IRAP inhibitors in bioassays (Engen et al., 2020) (Figure 10)
& Coccia, E
Skin and hair claims vary widely in evidence quality
"Stress in gastrointestinal tract and stable gastric pentadecapeptide BPC 157." Current Pharmaceutical Design
Conclusion: Cinchonine, a potential oral small-molecule GLP-1R agonist, could reduce blood glucose and ameliorate NASH, providing a strategy for developing small-molecule GLP-1R agonists